PubMed:16920333 / 1162-1318 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCoin-sentences

    {"project":"LitCoin-sentences","denotations":[{"id":"T7","span":{"begin":0,"end":156},"obj":"Sentence"}],"text":"No adverse effects of eslicarbazepine acetate were observed in the behavioral/EEG patterns studied, including sleep/wakefulness cycle, at the doses studied."}

    LitCoin-entities

    {"project":"LitCoin-entities","denotations":[{"id":"3378","span":{"begin":22,"end":45},"obj":"ChemicalEntity"}],"attributes":[{"id":"A26","pred":"db_id","subj":"3378","obj":"MESH:C416835"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"No adverse effects of eslicarbazepine acetate were observed in the behavioral/EEG patterns studied, including sleep/wakefulness cycle, at the doses studied."}

    LitCoin-GeneOrGeneProduct-v0

    {"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T21","span":{"begin":38,"end":45},"obj":"GeneOrGeneProduct"},{"id":"T22","span":{"begin":67,"end":77},"obj":"GeneOrGeneProduct"},{"id":"T23","span":{"begin":116,"end":127},"obj":"GeneOrGeneProduct"},{"id":"T24","span":{"begin":128,"end":133},"obj":"GeneOrGeneProduct"}],"text":"No adverse effects of eslicarbazepine acetate were observed in the behavioral/EEG patterns studied, including sleep/wakefulness cycle, at the doses studied."}

    LitCoin-GeneOrGeneProduct-v2

    {"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T13","span":{"begin":128,"end":133},"obj":"GeneOrGeneProduct"}],"text":"No adverse effects of eslicarbazepine acetate were observed in the behavioral/EEG patterns studied, including sleep/wakefulness cycle, at the doses studied."}

    LitCoin-Chemical-MeSH-CHEBI

    {"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T26","span":{"begin":22,"end":45},"obj":"ChemicalEntity"},{"id":"T28","span":{"begin":78,"end":81},"obj":"ChemicalEntity"}],"attributes":[{"id":"A26","pred":"ID:","subj":"T26","obj":"C416835"},{"id":"A27","pred":"ID:","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_87016"},{"id":"A28","pred":"ID:","subj":"T28","obj":"http://purl.obolibrary.org/obo/CHEBI_73494"}],"text":"No adverse effects of eslicarbazepine acetate were observed in the behavioral/EEG patterns studied, including sleep/wakefulness cycle, at the doses studied."}

    LitCoin-training-merged

    {"project":"LitCoin-training-merged","denotations":[{"id":"T28","span":{"begin":78,"end":81},"obj":"ChemicalEntity"},{"id":"T26","span":{"begin":22,"end":45},"obj":"ChemicalEntity"}],"attributes":[{"id":"A28","pred":"ID:","subj":"T28","obj":"http://purl.obolibrary.org/obo/CHEBI_73494"},{"id":"A27","pred":"ID:","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_87016"},{"id":"A26","pred":"ID:","subj":"T26","obj":"C416835"}],"text":"No adverse effects of eslicarbazepine acetate were observed in the behavioral/EEG patterns studied, including sleep/wakefulness cycle, at the doses studied."}